Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-Week, Double-Blind, Randomized Placebo-Controlled Study

被引:0
|
作者
Lunzer, R. [1 ]
机构
[1] Krankenhaus Barmherzigen Bruder Graz Eggenberg, Interne Abt, Bergstr 27, A-8020 Graz, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:60 / 60
页数:1
相关论文
共 50 条
  • [1] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study
    Tanaka, Yoshiya
    Emoto, Kahaku
    Cai, Zhihong
    Aoki, Takehiro
    Schlichting, Douglas
    Rooney, Terence
    Macias, William
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 504 - 511
  • [2] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study (vol 43, pg 504, 2016)
    Tanaka, Y.
    Emoto, K.
    Cai, Z.
    Aoki, T.
    Schlichting, D.
    Rooney, T.
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 999 - 999
  • [3] A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: A 12-week, double-blind, randomized, placebo-controlled study
    Lan, JL
    Chou, SJ
    Chen, DY
    Chen, YH
    Hsieh, TY
    Young, M
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (08) : 618 - 623
  • [4] Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study
    Inagaki, N.
    Kondo, K.
    Yoshinari, T.
    Maruyama, N.
    Susuta, Y.
    Kuki, H.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1136 - 1145
  • [5] Etoricoxib in the treatment of rheumatoid arthritis: A 12-week, placebo-controlled and active-comparator, double-blind US study
    Melian, A
    Curtis, S
    Matsumoto, A
    Zhao, PL
    McCormick, CL
    Rodgers, DB
    Gertz, BJ
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [6] Efficacy and Safety of Ketoprofen Patch in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study
    Kawai, Shinichi
    Uchida, Eiji
    Kondo, Masakazu
    Ohno, Syuji
    Obata, Junichi
    Nawata, Yasushi
    Sugimoto, Kazunori
    Oribe, Motohiro
    Nagaya, Ikuo
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (10): : 1171 - 1179
  • [7] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [8] Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: A 12-week, multicenter, randomized, double-blind, placebo-controlled study
    Gibofsky, Allan
    Rodrigues, Jude
    Fiechtner, Justus
    Berger, Manuela
    Pan, Sharon
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (06) : 1071 - 1085
  • [9] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
    van Dongen, Henrike
    van Aken, Jill
    Lard, Leroy R.
    Visser, Karen
    Ronday, H. Karel
    Hulsmans, Harry M. J.
    Speyer, Irene
    Westedt, Marie-Louise
    Peeters, Andre J.
    Allaart, Cornelia F.
    Toes, Rene E. M.
    Breedveld, Ferdinand C.
    Huizinga, Tom W. J.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
  • [10] Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
    Hobbs, Kathryn
    Deodhar, Atul
    Wang, Brian
    Bitman, Bojena
    Nussbaum, Joyce
    Chung, James
    Collier, David H.
    [J]. SPRINGERPLUS, 2015, 4 : 1 - 7